Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
2022 · International Journal of Pharmaceutics · 6 citations
https://doi.org/10.1016/j.ijpharm.2022.121959
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
1.2K
Citations
16
h-index
19
i10-index
Antti Rahikkala is an academic researcher from University of Helsinki. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Advanced Polymer Synthesis and Characterization & Microfluidic and Capillary Electrophoresis Applications. The author has an h-index of 16, co-authored 31 publications.
ORCID: 0000-0003-3846-3249Click to start Chat